These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 12522438)

  • 41. Antibiotic-dependent expression of early transcription factor subunits leads to stringent control of vaccinia virus replication.
    Hagen CJ; Titong A; Sarnoski EA; Verardi PH
    Virus Res; 2014 Mar; 181():43-52. PubMed ID: 24394294
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Antiviral action of nucleases and histones].
    Chizhov NP
    Vopr Virusol; 1974; (6):647-52. PubMed ID: 4374831
    [No Abstract]   [Full Text] [Related]  

  • 43. Replication-defective recombinant herpes simplex virus vectors.
    Johnson PA; Friedmann T
    Methods Cell Biol; 1994; 43 Pt A():211-30. PubMed ID: 7823863
    [No Abstract]   [Full Text] [Related]  

  • 44. Viral vectors for gene therapy.
    Robbins PD; Tahara H; Ghivizzani SC
    Trends Biotechnol; 1998 Jan; 16(1):35-40. PubMed ID: 9470229
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Poxvirus vectors: cytoplasmic expression of transferred genes.
    Moss B
    Curr Opin Genet Dev; 1993 Feb; 3(1):86-90. PubMed ID: 8453278
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Production of viral vectors for gene therapy applications.
    Wu N; Ataai MM
    Curr Opin Biotechnol; 2000 Apr; 11(2):205-8. PubMed ID: 10753765
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CELL CULTURE STUDIES ON ANTIVIRAL AGENTS. I. ACTION OF CYTOSINE ARABINOSIDE AND SOME COMPARISONS WITH 5-IODO-2-DEOXYURIDINE.
    BUTHALA DA
    Proc Soc Exp Biol Med; 1964 Jan; 115():69-77. PubMed ID: 14117474
    [No Abstract]   [Full Text] [Related]  

  • 48. [Nonspecific inhibitors in normal rat serum against influenza virus C; correlation between influenza C, Newcastle disease, and epidemic parotitis viruses].
    STYK B
    Ceskoslov Biol; 1955 May; 4(5):263-8. PubMed ID: 13261197
    [No Abstract]   [Full Text] [Related]  

  • 49. Viral teratology.
    Fuccillo DA; Sever JL
    Bacteriol Rev; 1973 Mar; 37(1):19-31. PubMed ID: 4369438
    [No Abstract]   [Full Text] [Related]  

  • 50. Replication-defective herpes simplex virus vectors for gene transfer in vivo.
    Marconi P; Krisky D; Oligino T; Poliani PL; Ramakrishnan R; Goins WF; Fink DJ; Glorioso JC
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11319-20. PubMed ID: 8876133
    [No Abstract]   [Full Text] [Related]  

  • 51. Vaccinia viral/retroviral chimeric vectors.
    Falkner FG; Holzer GW
    Curr Gene Ther; 2004 Dec; 4(4):417-26. PubMed ID: 15578991
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Viral vectored vaccines: design, development, preventive and therapeutic applications in human diseases.
    Wang S; Liang B; Wang W; Li L; Feng N; Zhao Y; Wang T; Yan F; Yang S; Xia X
    Signal Transduct Target Ther; 2023 Apr; 8(1):149. PubMed ID: 37029123
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Viral vector vaccines protect cockatiels from inflammatory lesions after heterologous parrot bornavirus 2 challenge infection.
    Runge S; Olbert M; Herden C; Malberg S; Römer-Oberdörfer A; Staeheli P; Rubbenstroth D
    Vaccine; 2017 Jan; 35(4):557-563. PubMed ID: 28017426
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Highly efficient induction of protective immunity by a vaccinia virus vector defective in late gene expression.
    Holzer GW; Remp G; Antoine G; Pfleiderer M; Enzersberger OM; Emsenhuber W; Hämmerle T; Gruber F; Urban C; Falkner FG; Dorner F
    J Virol; 1999 Jun; 73(6):4536-42. PubMed ID: 10233911
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Disinfection of influenza, mumps and Newcastle viruses in adsorbing medium].
    GRAFE A; HAUSSMANN HG
    Z Hyg Infektionskr; 1956; 143(3):304-18. PubMed ID: 13401976
    [No Abstract]   [Full Text] [Related]  

  • 56. [Proteolytic enzymes in virological studies].
    Lozitskiĭ VP; Degtiarenko VI
    Vopr Virusol; 1974; (2):131-7. PubMed ID: 4374820
    [No Abstract]   [Full Text] [Related]  

  • 57. Replicating viruses as selective cancer therapeutics.
    Kirn DH; McCormick F
    Mol Med Today; 1996 Dec; 2(12):519-27. PubMed ID: 9015793
    [TBL] [Abstract][Full Text] [Related]  

  • 58. ASCITES TUMOURS FROM BHK.21 CELLS TRANSFORMED IN VITRO BY POLYOMA VIRUS.
    SANDERS FK; BURFORD BO
    Nature; 1964 Feb; 201():786-9. PubMed ID: 14161203
    [No Abstract]   [Full Text] [Related]  

  • 59. Some highlights of animal virus research in 1986.
    McGeoch DJ; Howard CR; Desselberger U
    J Gen Virol; 1987 Jun; 68 ( Pt 6)():1501-24. PubMed ID: 3108450
    [No Abstract]   [Full Text] [Related]  

  • 60. From ONYX-015 to armed vaccinia viruses: the education and evolution of oncolytic virus development.
    Crompton AM; Kirn DH
    Curr Cancer Drug Targets; 2007 Mar; 7(2):133-9. PubMed ID: 17346104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.